# Microcaps

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microcaps

- Industry: Industrial Machinery
- Headquarters: Schlieren, Switzerland
- Website: www.microcaps.ch
- Total disclosed funding: $16M
- Latest round: Series A (Jun 5, 2024)
- Investors on record: 4

## About

Founded in 2018 by Alessandro Ofner and Michael Hagander, and based in Schlieren, Switzerland, Microcaps AG, a part of ETH Zurich’s Complex Material Group, operates as a developer of microcapsules for medicinal substances. In June 2024, Microcaps AG raised CHF 9.3 million in Series A funding from Helvetica Capital, Zürcher Kantonalbank, and the ETH Zürich Foundation.

The firm develops and offers technology that enhances the scalability of microcapsule production, achieving an increase in controlled microencapsulation compared to conventional methods. The firm uses its proprietary step emulsification device, ensuring precise and consistent encapsulation. The company provides a versatile and scalable solution, applicable across various industries such as cosmetics, nutrition, and pharmaceuticals.

The company intends to use the June 2024 funding to accelerate its production.

## Funding rounds

- Series A, Jun 5, 2024, $10M — Zürcher Kantonalbank, Helvetica Capital, ETH Foundation
- Seed, Jan 26, 2021, $5.7M — Zürcher Kantonalbank, Helvetica Capital, ETH Foundation, Lichtsteiner Foundation

## Investors

- Zürcher Kantonalbank — Seed, Series A
- Helvetica Capital (https://capitalatlas.ai/funds/helvetica-capital) — Seed, Series A
- ETH Foundation — Seed, Series A
- Lichtsteiner Foundation — Seed